ArticleBMC cancer2026

The effect of adding ovarian function suppression to adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive, HER2-positive breast cancer who have undergone neoadjuvant therapy: a single-center experience.

Okan Aydin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.